SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-1,763 Cr | ₹-2,987 Cr | ₹-2,714 Cr | ₹-1,998 Cr | ₹-1,316 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹-1,763 Cr |
| Mar2025 | ₹-2,987 Cr |
| Mar2024 | ₹-2,714 Cr |
| Mar2023 | ₹-1,998 Cr |
| Mar2022 | ₹-1,316 Cr |
How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,763 Cr | Negative | |
| Mar2025 | ₹-2,987 Cr | Negative | |
| Mar2024 | ₹-2,714 Cr | Negative | |
| Mar2023 | ₹-1,998 Cr | Negative | |
| Mar2022 | ₹-1,316 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,273.3 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,376.0 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.4% |
-6.2% |
11.8% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses